Home

Social Media Buzz 2/12/13

Immune Pharmaceuticals and EpiCept amend merger agreement to allow Immune to purchase up to $0.5 million new EpiCept common stock

KV Pharmaceutical to file quarterly report late

ViroPharma to participate In two upcoming healthcare investor conferences